Biosimilar Newsletter Archive
-
09.26.23 -- Optimize Your Cell Line Preparation
9/26/2023
09/26/23 Biosimilar Development Newsletter
-
09.25.23 -- Improve Your Productivity With The Use Of Effective Modular Systems
9/25/2023
09/25/23 Biosimilar Development Newsletter
-
09.21.23 -- De-Risking Biosimilar Development With A Clinically Validated And Commercially Proven Disposable Autoinjector
9/21/2023
09/21/23 Biosimilar Development Newsletter
-
09.14.23 -- Biosimilars Forum Statement On CMS Announcement Of Drug Negotiation List
9/14/2023
09/14/23 Biosimilar Development Newsletter
-
09.13.23 -- Affinity Chromatography For mAbs, Mechanistic Modeling, And Polishing
9/13/2023
09/13/23 Biosimilar Development Newsletter
-
09.07.23 -- FDA Approves First Biosimilar To Treat MS
9/7/2023
09/07/23 Biosimilar Development Newsletter
-
08.31.23 -- The Cancer Drug Shortage: When Quality Fails
8/31/2023
08/31/23 Biosimilar Development Newsletter
-
08.30.23 -- Futureproof The Design Of Your Biomanufacturing Capacity
8/30/2023
08/30/23 Biosimilar Development Newsletter
-
08.24.23 -- Key Post-Pandemic Trends In Global FDA Facility Observations
8/24/2023
08/24/23 Biosimilar Development Newsletter
-
08.23.23 -- Mitigating Particulate Risk For Your Injectable Drug Product
8/23/2023
08/23/23 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more